Bausch + Lomb Corp. and Novaliq say the FDA approved Miebo for the treatment of the signs and symptoms of dry eye disease.
- Sees MIEBO commercially available in 2H 2023
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2023 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.